{
    "Trade/Device Name(s)": [
        "BD Phoenix Automated Microbiology System",
        "BD Phoenix CPO detect - GN"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K181665",
    "Predicate Device Reference 510(k) Number(s)": [
        "K033458"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "June 19, 2018",
    "Summary Letter Received Date": "June 25, 2018",
    "Submission Date": "June 19, 2018",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully automated short-term incubation cycle antimicrobial susceptibility system"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Carbapenemase (Ambler Class A, Class B, Class D)",
        "Gram-negative bacteria",
        "Enterobacteriaceae",
        "Pseudomonas aeruginosa",
        "Acinetobacter baumannii"
    ],
    "Specimen Type(s)": [
        "Isolated bacterial colonies from culture"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Automated growth-based technology",
        "Broth-based microdilution",
        "Redox indicator",
        "Multiplex PCR (genotypic Ambler classification reference)",
        "Modified Carbapenem Inactivation Method (mCIM, phenotypic reference)"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "Phenotypic detection",
        "Genotypic classification"
    ],
    "Submission Type(s)": [
        "System",
        "Panel",
        "Test",
        "Instrument",
        "Software",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System and BD Phoenix CPO detect - GN for rapid identification and antimicrobial susceptibility testing of Gram-negative bacteria including carbapenemase detection and Ambler classification",
    "Indications for Use Summary": "Intended for rapid in vitro identification and quantitative determination of antimicrobial susceptibility by MIC for Gram Negative aerobic and facultative anaerobic bacteria and phenotypic detection of carbapenemase production including Ambler classification in Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii.",
    "fda_folder": "Microbiology"
}